These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 24063380)

  • 1. Antenatal hypoxia and pulmonary vascular function and remodeling.
    Papamatheakis DG; Blood AB; Kim JH; Wilson SM
    Curr Vasc Pharmacol; 2013 Sep; 11(5):616-40. PubMed ID: 24063380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.
    Nozik-Grayck E; Suliman HB; Majka S; Albietz J; Van Rheen Z; Roush K; Stenmark KR
    Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L422-30. PubMed ID: 18599502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
    Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
    Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension.
    Christou H; Reslan OM; Mam V; Tanbe AF; Vitali SH; Touma M; Arons E; Mitsialis SA; Kourembanas S; Khalil RA
    Am J Physiol Lung Cell Mol Physiol; 2012 May; 302(9):L875-90. PubMed ID: 22287610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Role of ROS in the Process of 15-Lipoxygenase/15-Hydroxyeicosatetraenoiccid-Induced Pulmonary Vascular Remodeling in Hypoxia Pulmonary Hypertension.
    Li Q; Mao M; Qiu Y; Liu G; Sheng T; Yu X; Wang S; Zhu D
    PLoS One; 2016; 11(2):e0149164. PubMed ID: 26871724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced hypoxic pulmonary vascular remodeling by nitric oxide from the endothelium.
    Ozaki M; Kawashima S; Yamashita T; Ohashi Y; Rikitake Y; Inoue N; Hirata KI; Hayashi Y; Itoh H; Yokoyama M
    Hypertension; 2001 Feb; 37(2):322-7. PubMed ID: 11230292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation.
    Imamura M; Luo B; Limbird J; Vitello A; Oka M; Ivy DD; McMurtry IF; Garat CV; Fallon MB; Carter EP
    J Appl Physiol (1985); 2005 Feb; 98(2):739-47. PubMed ID: 15516365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive Oxygen Species in COPD-Related Vascular Remodeling.
    Zuo L; Chuang CC; Clark AD; Garrison DE; Kuhlman JL; Sypert DC
    Adv Exp Med Biol; 2017; 967():399-411. PubMed ID: 29047102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic pulmonary vasoconstriction: role of ion channels.
    Mauban JR; Remillard CV; Yuan JX
    J Appl Physiol (1985); 2005 Jan; 98(1):415-20. PubMed ID: 15591311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide.
    Weissmann N; Nollen M; Gerigk B; Ardeschir Ghofrani H; Schermuly RT; Gunther A; Quanz K; Fink L; Hänze J; Rose F; Seeger W; Grimminger F
    Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H931-8. PubMed ID: 12433654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice.
    Levi M; Moons L; Bouché A; Shapiro SD; Collen D; Carmeliet P
    Circulation; 2001 Apr; 103(15):2014-20. PubMed ID: 11306532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice.
    Pascaud MA; Griscelli F; Raoul W; Marcos E; Opolon P; Raffestin B; Perricaudet M; Adnot S; Eddahibi S
    Am J Respir Cell Mol Biol; 2003 Oct; 29(4):449-57. PubMed ID: 12714372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling.
    Pokreisz P; Fleming I; Kiss L; Barbosa-Sicard E; Fisslthaler B; Falck JR; Hammock BD; Kim IH; Szelid Z; Vermeersch P; Gillijns H; Pellens M; Grimminger F; van Zonneveld AJ; Collen D; Busse R; Janssens S
    Hypertension; 2006 Apr; 47(4):762-70. PubMed ID: 16505204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced pulmonary vascular remodeling: cellular and molecular mechanisms.
    Stenmark KR; Fagan KA; Frid MG
    Circ Res; 2006 Sep; 99(7):675-91. PubMed ID: 17008597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn piglets.
    Binns-Loveman KM; Kaplowitz MR; Fike CD
    Pediatr Pulmonol; 2005 Jul; 40(1):72-80. PubMed ID: 15880376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic pulmonary hypertension of the newborn.
    Gao Y; Raj JU
    Compr Physiol; 2011 Jan; 1(1):61-79. PubMed ID: 23737164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The principal pathways involved in the in vivo modulation of hypoxic pulmonary vasoconstriction, pulmonary arterial remodelling and pulmonary hypertension.
    Kylhammar D; Rådegran G
    Acta Physiol (Oxf); 2017 Apr; 219(4):728-756. PubMed ID: 27381367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
    Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
    Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
    Ono S; Westcott JY; Voelkel NF
    J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.
    Lahm T; Albrecht M; Fisher AJ; Selej M; Patel NG; Brown JA; Justice MJ; Brown MB; Van Demark M; Trulock KM; Dieudonne D; Reddy JG; Presson RG; Petrache I
    Am J Respir Crit Care Med; 2012 May; 185(9):965-80. PubMed ID: 22383500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.